Back to Search Start Over

45P Durvalumab (D) plus gemcitabine-based (gem-based) chemotherapy as first-line therapy for Chinese patients (pts) with advanced biliary tract cancers (aBTC): A phase IIIb, single arm, open-label, multi-center study (TopDouble).

Authors :
Sun, H.
Zhou, J.
Qin, S.
Zheng, T.
Geng, Z.
Yuan, Y.
Liu, J.
Li, H.
Gu, S.
Li, T.
Zhang, B.
Yue, J.
Zhao, H.
Liu, L-X.
Huang, Z.
Zhang, Z.
LI, J.
Zhang, J.
Su, Z.
Source :
Annals of Oncology. 2024 Supplement 2, Vol. 35, pS229-S229. 1p.
Publication Year :
2024

Subjects

Subjects :
*CHINESE people
*CANCER chemotherapy
BILIARY tract cancer

Details

Language :
English
ISSN :
09237534
Volume :
35
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
179691473
Full Text :
https://doi.org/10.1016/j.annonc.2024.08.054
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details